Every record from PeptideMeter · page 5
Runs dual-wavelength detection as standard and reports named related substances rather than totals only. Measured offset against the reference laboratory is -0.024 pp on 569 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042157 | GHRP-2 | Homopeptide | HOMO-2602-E9033 | 2026-Q2 | 99.93 | 4.32 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042033 | Gonadorelin | TFC | TFC-2511-E6450 | 2026-Q2 | 99.48 | 2.96 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041853 | ARA-290 | JEEP | JEEP-2601-K3139 | 2026-Q2 | 98.50 | 4.51 | 94.7 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041292 | Semaglutide | WWB | WWB-2603-N3120 | 2026-Q2 | 98.81 | 6.41 | 93.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041214 | Thymulin | WWB | WWB-2602-S2129 | 2026-Q2 | 98.91 | 4.03 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043562 | GHRP-6 | BCH | BCH-2603-Y7018 | 2026-Q2 | 98.57 | 4.52 | 97.9 | Supplier-supplied | 1 | FAIL |
| AX-2026-041891 | Melanotan II | JEEP | JEEP-2604-R3923 | 2026-Q2 | 99.77 | 5.14 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041248 | GHK-Cu | WWB | WWB-2512-B1996 | 2026-Q2 | 99.04 | 6.05 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041220 | Thymulin | WWB | WWB-2602-S2129 | 2026-Q2 | 99.05 | 3.36 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043243 | Melanotan II | SGN | SGN-2602-L1809 | 2026-Q2 | 98.92 | 2.81 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042810 | Retatrutide | GGPeps | GGPE-2603-M1446 | 2026-Q2 | 97.79 | 3.88 | 98.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041522 | Retatrutide | QYB | QYB-2602-R6263 | 2026-Q2 | 97.87 | 5.49 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043120 | Mazdutide | SSA | SSA-2605-G6781 | 2026-Q2 | 98.74 | 3.24 | 104.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042084 | PT-141 (Bremelanotide) | TFC | TFC-2512-V7681 | 2026-Q2 | 99.06 | 3.72 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041354 | BPC-157 | WWB | WWB-2604-B3510 | 2026-Q2 | 99.93 | 5.10 | 106.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041265 | Ipamorelin | WWB | WWB-2511-M1961 | 2026-Q2 | 99.67 | 7.08 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043143 | GHK-Cu | SSA | SSA-2604-V7620 | 2026-Q2 | 97.96 | 4.60 | 102.7 | Buyer-sourced | 0 | PASS |
| AX-2026-042097 | Retatrutide | TFC | TFC-2512-G7985 | 2026-Q2 | 99.11 | 2.40 | 99.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043530 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2511-G7276 | 2026-Q2 | 98.55 | 4.28 | 88.8 | Supplier-supplied | 2 | FAIL |
| AX-2026-041948 | Semax | TFC | TFC-2602-F4591 | 2026-Q2 | 99.28 | 8.46 | — | Laboratory-retained | 0 | PASS |
| AX-2026-043241 | Melanotan II | SGN | SGN-2602-L1809 | 2026-Q2 | 98.80 | 2.57 | 106.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043218 | SLU-PP-332 | SGN | SGN-2602-X9969 | 2026-Q2 | 97.86 | 6.10 | 102.8 | Supplier-supplied | 0 | FAIL |
| AX-2026-042854 | Retatrutide | GGPeps | GGPE-2601-C2423 | 2026-Q2 | 97.52 | 4.37 | 88.7 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042852 | Retatrutide | GGPeps | GGPE-2601-C2423 | 2026-Q2 | 97.73 | 3.87 | 89.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042918 | Gonadorelin | MKM | MKM-2604-A2596 | 2026-Q2 | 99.93 | 5.24 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042114 | PT-141 (Bremelanotide) | TFC | TFC-2512-M8211 | 2026-Q2 | 98.73 | 7.99 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041447 | Liraglutide | QYB | QYB-2511-V5143 | 2026-Q2 | 99.06 | 5.19 | 100.8 | Supplier-supplied | 0 | PASS |
| AX-2026-043006 | Tirzepatide | KP | KP-2602-X5446 | 2026-Q2 | 98.28 | 6.28 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042430 | IGF-1 DES (1-3) | SWB | SWB-2601-Y5870 | 2026-Q2 | 97.95 | 3.81 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043451 | BPC-157 | WXT | WXT-2602-W4680 | 2026-Q2 | 98.11 | 5.42 | 106.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042784 | Selank | GGPeps | GGPE-2601-J1391 | 2026-Q2 | 99.93 | 9.13 | 95.6 | Supplier-supplied | 0 | PASS |
| AX-2026-042580 | SLU-PP-332 | GGPeps | GGPE-2511-R8569 | 2026-Q2 | 98.67 | 4.40 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041467 | SS-31 (Elamipretide) | QYB | QYB-2512-H5402 | 2026-Q2 | 99.86 | 5.21 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043259 | BPC-157 | SGN | SGN-2512-H1950 | 2026-Q2 | 98.19 | 4.30 | 96.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042754 | 5-Amino-1MQ | GGPeps | GGPE-2512-M9695 | 2026-Q2 | 99.20 | 4.90 | 96.8 | Supplier-supplied | 2 | FAIL |
| AX-2026-041625 | BPC-157 | QSC | QSC-2511-N8732 | 2026-Q2 | 99.93 | 5.63 | 104.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043226 | SLU-PP-332 | SGN | SGN-2602-X9969 | 2026-Q2 | 97.81 | 5.25 | 95.9 | Buyer-sourced | 0 | FAIL |
| AX-2026-042819 | TB-500 | GGPeps | GGPE-2605-J2051 | 2026-Q2 | 99.70 | 4.70 | 94.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042786 | Selank | GGPeps | GGPE-2601-J1391 | 2026-Q2 | 99.55 | 9.56 | 104.7 | Supplier-supplied | 0 | PASS |
| AX-2026-042602 | Tirzepatide | GGPeps | GGPE-2604-H8313 | 2026-Q2 | 99.59 | 1.92 | 89.5 | Supplier-supplied | 2 | MARGINAL |